This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Clinical classification of oral candidiasis

Authoring team

Clinical classification of oral candidiasis (1,2)

 

Proposed revised classification of oral Candidiasis

 

Primary oral candidiasis (Group I)

 

  • acute
    • pseudomembranous
    • erythematous

  • chronic
    • erythematous
    • pseudomembranous
    • hyperplastic
    • nodular
    • plaque-like
  • Candida-associated lesions
    • angular cheilitis
    • denture stomatitis
    • median rhomboid glossitis

 

  • keratinized primary lesions superinfected with Candida
    • leukoplakia
    • lichen planus
    • lupus erythematosus.

 

Secondary oral candidiasis (Group II)

 

  • oral manifestations of Systemic mucocutaneous.

 

  • Candidiasis (due to diseases such as thymic aplasia and candidiasis endocrinopathy syndrome).

 

References

1. Singh A, Verma R, Murari A, Agrawal A. Oral candidiasis: An overview. Journal of Oral and Maxillofacial Pathology: JOMFP. 2014;18(Suppl 1):S81-S85.

2. Neville BA, Damm DD, Allen CM, et al. Fungal and protozoal diseases. In: Oral & maxillofacial pathology. 4th ed. Philadelphia: W.B. Saunders Company; 2015.

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.